A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of LY3031207 in Healthy Subjects
Latest Information Update: 07 Nov 2021
At a glance
- Drugs LY 3031207 (Primary) ; Celecoxib; Simvastatin
- Indications Arthritis; Dyslipidaemias; Pain
- Focus Adverse reactions
- 31 Jan 2013 Planned End Date changed from 1 Jan 2013 to 1 Apr 2013 as reported by ClinicalTrials.gov.
- 06 Dec 2012 Planned end date changed from 1 Dec 2012 to 1 Jan 2013 as reported by ClinicalTrials.gov.
- 25 Oct 2012 Planned End Date changed from 1 Oct 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.